Videoconferencing & HCV Care

Appointment Viewing Can videoconferencing improve outcomes for hep C patients who have used IV drugs? by Larry Buhl Thanks to a $7 million grant from the Patient-Centered...

Full Access: Interview with Dr. Stacy Trooskin

Full Access Examining a legal victory for incarcerated Pennsylvanians with hep C by Larry Buhl With the advent of antiretroviral drugs, a cure for hepatitis C has...

New Generation DDAs

Six drugs promise to further revolutionize HCV treatments by Larry Buhl The hepatitis C (HCV) treatment revolution is a little more than a year old, but...

Taking a Toll

LifeGuide Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested...

Don’t Fear the Treatment

HCV advocate, author & nurse Lucinda Porter offers perspectives on care by Larry Buhl Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and...

Snorting Utensils & Hep C Risk

Last Straw New research shows snorting utensils carry a high risk of transmitting HCV by Larry Buhl The risk of contracting the hepatitis C virus (HCV) and...

REALIZE Gets Real

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

Interferon-Free C

Hep Talk by Larry Buhl <strong>Warp Speeds <p> CROI researchers predict oral-only interferon-free treatment by 2014</strong><p> <a href="http://aumag.org/wordpress/wp-content/uploads/2013/06/warp_speed.jpg"><img src="http://aumag.org/wordpress/wp-content/uploads/2013/06/warp_speed.jpg" alt="warp_speed" width="600" height="450" class="alignleft size-full wp-image-7443" /></a><p> Advances leading...

HCV Treatment Choices & Coverage Restrictions

Decisions, Decisions There are HCV treatment choices to make, but often few options by Larry Buhl If you’ve tested positive for the hepatitis C virus (HCV), there...

Right Around the Corner

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...

LATEST POSTS

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...

5B, or Not to 5B

Jason Bennett: Advocate